These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29440586)

  • 1. National Practice Patterns of Obtaining Informed Consent for Stroke Thrombolysis.
    Mendelson SJ; Courtney DM; Gordon EJ; Thomas LF; Holl JL; Prabhakaran S
    Stroke; 2018 Mar; 49(3):765-767. PubMed ID: 29440586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Informed Consent for Thrombolysis in Acute Ischemic Stroke.
    Comer AR; Damush TM; Torke AM; Williams LS
    J Clin Ethics; 2019; 30(4):338-346. PubMed ID: 31851625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents.
    Zonjee VJ; Slenders JPL; de Beer F; Visser MC; Ter Meulen BC; Van den Berg-Vos RM; van Schaik SM
    BMC Med Ethics; 2021 Aug; 22(1):114. PubMed ID: 34433444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
    Weintraub MI
    Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.
    Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.
    Xu H; De Silva DA; Woon FP; Ong MEH; Matchar DB; Bettger JP; Laskowitz DT; Xian Y
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105551. PubMed ID: 33348248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.
    Rosenbaum JR; Bravata DM; Concato J; Brass LM; Kim N; Fried TR
    Stroke; 2004 Sep; 35(9):e353-5. PubMed ID: 15243145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consent to thrombolysis in acute ischaemic stroke: from trial to practice.
    Ciccone A
    Lancet Neurol; 2003 Jun; 2(6):375-8. PubMed ID: 12849154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Litigation regarding tPA and stroke.
    Pilcher CA
    Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
    [No Abstract]   [Full Text] [Related]  

  • 10. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study.
    Weber JE; Ebinger M; Rozanski M; Waldschmidt C; Wendt M; Winter B; Kellner P; Baumann A; Fiebach JB; Villringer K; Kaczmarek S; Endres M; Audebert HJ;
    Neurology; 2013 Jan; 80(2):163-8. PubMed ID: 23223534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
    Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
    Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002.
    Bateman BT; Schumacher HC; Boden-Albala B; Berman MF; Mohr JP; Sacco RL; Pile-Spellman J
    Stroke; 2006 Feb; 37(2):440-6. PubMed ID: 16397164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke.
    Ng FC; Coote S; Frost T; Bladin C; Choi PM
    Stroke; 2016 Jul; 47(7):1914-6. PubMed ID: 27197850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Thrombolysis Attenuates Neurologic Deterioration After Ischemic Stroke.
    Siegler JE; Martin-Schild S
    South Med J; 2016 Oct; 109(10):661-667. PubMed ID: 27706507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial.
    Kane I; Lindley R; Lewis S; Sandercock P;
    Cerebrovasc Dis; 2006; 21(5-6):348-52. PubMed ID: 16490945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.